HKU COVID-19 vaccine trials to start in July
Share - WeChat
A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Liaoning fire: Report urges legal action against restaurant operator and seven others
- Historical Han Dynasty slips go on display in Hohhot
- Shanghai unveils steps to build sci-tech innovation corridor in Yangtze River Delta
- Xiangchao concludes with Yongzhou claiming championship
- Answers
- CPC leadership meeting urges steadfast implementation of eight-point decision on improving conduct
































